IP Library Granted Patent US 12,569,892
Granted Patent B2
US 12,569,892 · App. 18/214,182 · Granted Mar 10, 2026

Methods and compositions for decontaminating PD catheters

Inventors: Garrick Lawrence Maenle (Arlington Heights, IL); Robert Radford (Evanston, IL); Cristian Adolfo Menzel Bueno (Gurnee, IL); Mark Edward Pasmore (Grayslake, IL); Shawn Collin Oppegard (Fox River Grove, IL)
Assignees: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE SA
B08B9/0321A61M1/285C11D1/37C11D3/2086C11D3/48A61M2025/0019B08B2209/032C11D1/143C11D1/146
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,569,892
App. No.
18/214,182
Granted
Mar 10, 2026
Kind
B2
Abstract

A method of performing peritoneal dialysis (PD), the method comprising: delivering a PD fluid to the peritoneal cavity of a patient through a PD catheter; dwelling the PD fluid within the peritoneal cavity; and while dwelling the PD fluid, removing a biofilm from the PD catheter wall using a biofilm removing solution. The biofilm removing solution comprises: sodium citrate dihydrate; citric acid anhydrous; sodium lauryl sulfate; and water. In another aspect, a method for decontaminating a peritoneal dialysis (PD) catheter and removing a biofilm from the PD catheter and a transfer set, the method comprising: providing a biofilm removing solution; transferring the biofilm removing solution into a syringe; connecting the syringe to a transfer set of the PD catheter; and filling the transfer set and the PD catheter with the biofilm removing solution.

Claims (70)

1 . A method of performing peritoneal dialysis (PD), the method comprising:

delivering a PD fluid to a peritoneal cavity of a patient through a PD catheter;

dwelling the PD fluid within the peritoneal cavity; and

while dwelling the PD fluid, removing a biofilm from a PD catheter wall using a biofilm removing solution,

wherein the biofilm removing solution consists of:

sodium citrate dihydrate;

citric acid anhydrous;

an alkyl sulfonate; and

water.

2 . The method of claim 1 , wherein the alkyl sulfonate is a metal sulfonate.

3 . The method of claim 2 , wherein the metal sulfonate is sodium lauryl sulfate.

4 . The method of claim 3 , wherein the biofilm removing solution has:

sodium citrate dihydrate in a concentration range of about 32.13 g/L to about 39.27 g/L;

citric acid anhydrous in a concentration range of about 29.25 g/L to about 35.75 g/L;

sodium lauryl sulfate in a concentration range of about 0.95 g/L to about 1.05 g/L; and

water.

5 . The method of claim 1 , wherein the biofilm removing solution has

a pH value in the range of about 3.70 to about 4.10;

a total citrates in a concentration range of about 57.45 g/L to about 70.21 g/L; and

a specific gravity in range of about 1.025 to about 1.042.

6 . The method of claim 1 , wherein the alkyl sulfonate is in a concentration range of about 0.61 g/L to about 1.10 g/L.

7 . A method of performing peritoneal dialysis (PD), the method comprising:

delivering a PD fluid to a peritoneal cavity of a patient through a PD catheter;

dwelling the PD fluid within the peritoneal cavity; and

while dwelling the PD fluid, removing a biofilm from a PD catheter wall using a biofilm removing solution,

wherein the biofilm removing solution consists of:

sodium citrate dihydrate;

citric acid anhydrous;

an alkyl sulfonate;

water; and

an antimicrobial ingredient.

8 . The method of claim 7 , wherein the antimicrobial ingredient is selected from the group consisting of: an antibiotic, a bleach and silver sulfadiazine.

9 . The method of claim 1 , wherein the PD fluid further includes an antibiotic for treating bacteria exposed by the removed biofilm.

10 . The method of claim 1 , wherein the step of removing the biofilm from the PD catheter wall using the biofilm removing solution comprises:

transferring the biofilm removing solution into a syringe;

fluidly communicating the syringe with a transfer set located along the PD catheter; and

filling the transfer set and the PD catheter with the biofilm removing solution.

11 . The method of claim 10 , wherein the step of removing the biofilm from the PD catheter wall using the biofilm removing solution further comprises:

closing a transfer set valve to keep the biofilm removing solution in the transfer set and the PD catheter for a first period of time.

12 . The method of claim 11 , wherein the first period of time is between about 1 hour and about 12 hours.

13 . The method of claim 11 , wherein the first period of time is between about 1 hour and about 1.8 hours.

14 . The method of claim 11 , wherein the first period of time is about 1.5 hours.

15 . The method of claim 13 , wherein the step of removing a biofilm from the PD catheter wall using the biofilm removing solution further comprises removing the biofilm removing solution, the PD fluid and the biofilm.

16 . The method of claim 15 , wherein the step of removing the biofilm removing solution, the PD fluid and the biofilm comprises:

replacing the syringe with appropriate fluid connection(s) to an effluent bag or other drain; and

opening the transfer set valve to drain the biofilm removing solution and the PD fluid into the effluent bag or other drain via gravity or pumping,

wherein the biofilm removing solution and the PD fluid comprise the biofilm removed from the transfer set and the PD catheter.

17 . The method of claim 15 , wherein the biofilm is removed from inner walls of the transfer set and the PD catheter and an outer wall of a portion of the PD catheter located within a patient's peritoneal cavity.

18 . A method of performing peritoneal dialysis (PD), the method comprising:

pumping a PD fluid including a biofilm removing solution to a peritoneal cavity of a patient through a PD catheter;

dwelling the PD fluid including a biofilm removing solution within the peritoneal cavity; and

while dwelling the PD fluid including a biofilm removing solution, removing a biofilm from the PD catheter wall via the biofilm removing solution,

wherein the biofilm removing solution consists of:

sodium citrate dihydrate;

citric acid anhydrous;

an alkyl sulfonate; and

water.

19 . The method of claim 18 , wherein the PD fluid further includes an antibiotic for treating bacteria exposed by the removed biofilm.

20 . The method of claim 18 , wherein the alkyl sulfonate is sodium lauryl sulfate.

21 . A method of removing at least a portion of a biofilm present in a lumen of an indwelling peritoneal catheter while performing peritoneal dialysis therapy, the method comprising:

delivering a dialysis fluid to a peritoneal cavity of a patient through the catheter;

injecting a biofilm removing solution into the lumen of the catheter to occupy at least a portion of the lumen;

dwelling the dialysis fluid within the peritoneal cavity; and

removing at least a portion of the biofilm removing solution from the catheter by withdrawing at least a portion of the dialysis fluid from the peritoneal cavity into the catheter,

wherein the biofilm removing solution consists of:

sodium citrate dihydrate;

citric acid anhydrous;

an alkyl sulfonate; and

water.

22 . The method of claim 21 , wherein the alkyl sulfonate is sodium lauryl sulfate.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2025
From: BAXTER HEALTHCARE SA
To: VANTIVE HEALTH GMBH
Reel/Frame 073433/0234 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2025
From: BAXTER INTERNATIONAL INC.
To: VANTIVE US HEALTHCARE LLC
Reel/Frame 074046/0877 →
SECURITY INTEREST Recorded Jan 31, 2025
From: VANTIVE US HEALTHCARE LLC; GAMBRO RENAL PRODUCTS, INC.
To: ARES CAPITAL CORPORATION
Reel/Frame 070076/0701 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2023
From: MAENLE, GARRICK LAWRENCE; RADFORD, ROBERT; BUENO, CRISTIAN ADOLFO MENZEL; PASMORE, MARK EDWARD; OPPEGARD, SHAWN COLLIN
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE SA
Reel/Frame 064963/0340 →
Continuity (2)
Continuation In Part 17867053 · Jul 18, 2022
Related Publication 20240017303A1 · Jan 18, 2024
References Cited (3)
US 20170157311A1 · Egley · 2017 [cited by examiner]
US 20180185410A1 · Holmgren · 2018 [cited by examiner]
US 20190336714A1 · Vazales · 2019 [cited by examiner]